NTRA.NASDAQNatera, INC

Form 4: Natera CFO Michael Brophy Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Michael Brophy, CFO of Natera, Inc., reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

  • On June 28, 2024, Natera CFO Michael Brophy vested 12,500 restricted stock units (RSUs) that converted into common stock.
  • Following the vesting, Brophy sold 4,983 shares of common stock on July 1, 2024, at a price of $108.3658 per share.
  • The sale was executed to cover tax withholding obligations related to the RSU vesting, under a pre-arranged 10b5-1 trading plan.
  • After these transactions, Brophy directly owns 75,059 shares of Natera common stock and 12,500 RSUs.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. The sale of shares to cover tax obligations upon RSU vesting is a common practice.

Comparison to Industry Standards

  • Monitoring insider transactions is a standard practice in financial analysis.
  • Companies like Illumina (ILMN) and Exact Sciences (EXAS), which operate in similar genetic testing markets, are also subject to scrutiny regarding insider trading activity.
  • Comparing the frequency and nature of insider transactions at Natera to those of its peers can provide insights into management's confidence and potential future performance.

Key Dates

DateDescription
January 22, 2021Reporting Person was granted RSUs covering 25,000 shares of Common Stock which vest in tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price.
June 28, 2024Vesting of 12,500 Restricted Stock Units (RSUs).
July 01, 2024Sale of 4,983 shares at $108.3658 per share.
July 02, 2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.